Comtan Footer
For U.S. residents only Non-U.S. residents Novartis Pharma US
    Learn About Novartis
   
 

WHERE ARE YOU IN THE

Treatment of PD?

 
Find the information you need more quickly by selecting where you are in the treatment of PD:
>> Diagnosed with PD* >> Already taking STALEVO
>> Taking carbidopa/levodopa >> A care partner for a person with PD
  *STALEVO is indicated for certain patients with Parkinson's disease experiencing symptom reemergence due to "wearing-off."
 
 

With STALEVO you may have more active time
— almost an hour and a half each day (1.4 hours)

 

Parkinson's disease is a condition for which currently there is no cure. But with the right medication, you can manage your symptoms for longer periods of time.

STALEVO does more than carbidopa/levodopa alone. It has been clinically proven to deliver more active time during the day—almost an hour and a half each day (1.4 hours). So you can enjoy more time with fewer symptoms.

Talk to your health care professional (HCP) if you have questions about STALEVO.

 
 
 
      Stalevo
 
 
   
Orion Pharma  
 
 
 
Novartis Use of website is governed by the Terms of Use and Privacy Statement.
Copyright ©2010 Novartis Pharmaceuticals Corporation. All rights reserved.
 
3/10 - SLV-900358
 
Healthcare Professionals